Boston, MA, United States of America

Gen9, Inc.


USPTO Granted Patents = 44

% Expired Patents = 36.4



Trademarks = 1

Forward Citations = 1,103

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal Joseph M Jacobson (28 out of 143 patents)

silverMedal Michael E Hudson (14 out of 15 patents)

bronzeMedal Daniel Schindler (13 out of 14 patents)

4.  Larry Li-Yang Chu (11 out of 11 patents)

5.  Li-yun A Kung (8 out of 9 patents)

6.  Senthil Ramu (7 out of 7 patents)

7.  Scott S Lawton (6 out of 7 patents)

8.  Andrew V Oleinikov (6 out of 10 patents)

9.  Martin J Goldberg (5 out of 57 patents)

10.  Ishtiaq E Saaem (4 out of 4 patents)

11.  George M Church (3 out of 205 patents)

12.  Andrew Wilson (3 out of 11 patents)

13.  Mark A Fauci (3 out of 5 patents)

14.  Giles F Hall (2 out of 2 patents)

15.  Li-Yun A Kung (2 out of 2 patents)


Core Competencies:
Nucleic Acids
Polynucleotides
High Throughput Sequencing
Oligonucleotides
Protein Arrays
Microarrays
Gene Synthesis
Microfluidic Devices
DNA Error Reduction
Droplet Manipulation
Enzyme Catalysis

44 patents:

Gen9, Inc., based in Boston, MA, specializes in advanced nucleic acid technologies, focusing on the synthesis and assembly of nucleic acids. The company is recognized for its expertise in high throughput sequencing and the production of oligonucleotides, which are essential for various applications in genomics and synthetic biology. Gen9's innovative approaches to multiplex nucleic acids synthesis and polynucleotide synthesis position it as a key player in the biotechnology sector, contributing to advancements in research and development across multiple scientific fields.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Gen9, Inc.
44 Patents

#54 in Boston, MA

#454 in Massachusetts

#7,944 in US

#15,727 in the World

Boston, MA (US)
Boston, MA, United States of America
Forward Citations = 1,103

27 inventors:

Please report any incorrect information to [email protected]
Loading…